Browse Biological products topic

Health aspects subtopic

Articles 1-24 out of 24 article(s) Title Author Type Date Words Aphios Awarded NIH ARRA Challenge Grant for Pathogen Inactivation Technology for Blood Products. Sep 30, 2009 549 Receptor Logic, Inc. Awarded National Cancer Institute Grant. Sep 2, 2009 803 Resistance to HER2-directed trastuzumab therapy in breast cancer. Jasani, Bharat; Gee, Julia; Hutcheson, Iain; Clarkson, Richard W.; Bartlett, John; Barrett-Lee, Pete Report Sep 1, 2009 5989 Aphios Awarded NIH Grant for CFI Virus and Pathogen Inactivation Technology for Blood Products and Biologics. Aug 4, 2009 511 Seattle Genetics Initiates Phase II Trial of SGN-35 for Anaplastic Large Cell Lymphoma. Jun 18, 2009 862 Research and Markets: Therapeutic Peptides in Oncology - Favorable Conditions But Whereto Commercialize? Jun 11, 2009 411 ATCC Develops and Isolates Novel Avian Flu Monoclonal Antibodies. Mar 16, 2009 676 Mycobacterium haemophilum infection after alemtuzumab treatment. Kamboj, Mini; Louie, Eddie; Keihn, Timothy; Papanicolaou, Genovefa; Glickman, Michael; Sepkowitz, Ke Nov 1, 2008 1284 Use of Therapeutic Monoclonal Antibodies Increasing in Europe. Sep 15, 2008 539 Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer. Sep 8, 2008 1689 Robust solution for downstream processing of biotherapeutics: faced with tremendous cost pressures, the biomanufacturing industry is looking at options to simplify downstream processing. One solution is second-generation EBA purification alongside the development of disposable chromatography columns. Natalya Clark, Business Development Manager, Upfront Chromatography A/S, discusses these issues. Clark, Natalya Sep 1, 2008 1453 Analyse Therapeutic Clinical Intelligence - Rheumatoid Arthritis. Jan 7, 2008 503 Panacea announces selection of PAN-622 - a fully human sequence monoclonal antibody against HAAH - as its lead cancer therapeutic product. Nov 1, 2007 793 Review of molecular methods for medical microbiology testing. Evans, Gloria Nov 1, 2007 9047 Diagnostic HYBRIDS Announces Release of D3(R) DFA Varicella-zoster Virus Identification Kit. Sep 7, 2007 376 Pieris progresses development of its proprietary biotherapeutics platform. Jun 1, 2007 534 Invasive cryptococcosis and adalimumab treatment. Farinas, M. Carmen Letter to the editor Jun 1, 2007 1276 INSERTING and REPLACING GORE DUALMESH(R) PLUS Biomaterial Inhibits Implant Infections by Drug-Resistant 'Superbugs' and Resists Biofilm Development. Feb 14, 2007 643 Dyax Corp. and Serono Enter Into Library License and Funded Research Agreements for Discovery of Therapeutic Antibodies. Sep 7, 2006 722 Dyax Corp. and ICOS Corporation Enter Into License Agreement for Discovery of Therapeutic Antibodies. May 22, 2006 696 Caprion's caStx 1-2 Antibodies Receive European and US Orphan Drug Designation for Treatment of Shiga-Toxin Producing E. Coli. Dec 20, 2005 487 FDA Accepts CUBICIN(R) sNDA and Grants Priority Review. Nov 21, 2005 1063 Quantification the bioactivity of plant extracts during screening and bioassay guided fractionation. Eloff, J.N. Apr 1, 2004 1087 Australia agency moves to implement regulations of human tissue, emerging biological therapies. Brief Article Sep 15, 2003 240